Lysosome

**Lysosomes** are membrane-bound organelles present in nearly all mammalian cells, serving as key degradation and recycling centers for macromolecules via over 60 hydrolases, maintaining an acidic environment optimal for their activity[7]. Lysosomal function is crucial in macromolecule digestion, cellular waste clearance, recycling of catabolites, autophagy, immune processing, signaling, apoptosis, and energy metabolism[1][2][4][7]. Dysregulation of lysosomal activity or associated pathways contributes to lysosomal storage diseases, metabolic and neurodegenerative disorders, cancer, inflammation, infection, and aging[2][3][4][6]. Lysosomal activity itself is not a protein, receptor, or gene, but rather a dynamic state of lysosomal function. Thus, “lysosomal activity/modulation” is not a canonical molecule, receptor, or defined therapeutic target but refers to the modulation of lysosomal processes as a therapeutic strategy[2][4]. Therapies may target specific lysosomal enzymes, acidification processes, or biogenetic pathways, and include gene therapy, enzyme replacement, small molecule chaperones, or modulating upstream signals like mTOR and TFEB[2][3][6]. Safety challenges include widespread lysosomal presence, immune responses, limited organ targeting, and potential toxicity with nonspecific modulation[4][6]. **Note:** There is something incorrect with the submitted target: "Lysosomal activity/modulation" identifies a process, not a specific molecular target or receptor. Definitions, drugs, and mechanisms will necessarily refer to the broad organelle and its functions, not a single canonical target.

Other names

Lysosomal compartmentLysosomal organelle

Enzyme replacement; pH modulation (acidification or alkalinization); Inhibition or activation of lysosomal enzymes; Targeted delivery by receptor-mediated uptake (e.g., mannose-6-phosphate pathway); Modulation of lysosomal biogenesis or repair; Regulation of autophagy via signaling pathways (e.g., mTORC1 inhibition)